Evidence map›Paper›PMID 22430804›Full record

ArticleEpigenetics2012

Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.

Christopher J Ricketts, Mark R Morris, Dean Gentle, Michael Brown, Naomi Wake, Emma R Woodward, Noel Clarke, Farida Latif, Eamonn R Maher

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in pharmacology · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Clinical Significance ofOncoTargets and therapy · 2021
    Article
  8. Comprehensive Analysis of mInternational journal of genomics · 2021
    Article
  9. PMEnvironmental health and preventive medicine · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Knocking OutCancer management and research · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Christopher J RickettsCentre for Rare Diseases and Personalized Medicine, University of Birmingham, Birmingham, UK.
Mark R Morris
Dean Gentle
Michael Brown
Naomi Wake
Emma R Woodward
Noel Clarke
Farida Latif
Eamonn R Maher
NIHR Surgical Reconstruction and Microbiology Research Centre · GBCancer Research UK Clinical Trials Unit · GBUniversity of Birmingham · GBManchester Academic Health Science Centre · GBSpanish Oncology Genitourinary Group · ES

Funding

Department of Health DHCS/06/06/013
6 · The paper itself

Abstract

In order to identify novel candidate tumor suppressor genes (TSGs) implicated in renal cell carcinoma (RCC), we performed genome-wide methylation profiling of RCC using the HumanMethylation27 BeadChips to assess methylation at > 14,000 genes. Two hundred and twenty hypermethylated probes representing 205 loci/genes were identified in genomic CpG islands. A subset of TSGs investigated in detail exhibited frequent tumor methylation, promoter methylation associated transcriptional silencing and reactivation after demethylation in RCC cell lines and down-regulation of expression in tumor tissue (e.g., SLC34A2 specifically methylated in 63% of RCC, OVOL1 in 40%, DLEC1 in 20%, TMPRSS2 in 26%, SST in 31% and BMP4 in 35%). As OVOL1, a putative regulator of c-Myc transcription, and SST (somatostatin) had not previously been linked to cancer and RCC, respectively, we (1) investigated their potential relevance to tumor growth by RNAi knockdown and found significantly increased anchorage-independent growth and (2) demonstrated that OVOL1 knockdown increased c-Myc mRNA levels.

Indexed as

CpG IslandsDNA MethylationCarcinoma, Renal CellCell Line, TumorCluster AnalysisGenesHEK293 CellsHumansKidney NeoplasmsSequence AnalysisTumor Cells, Cultured

Identifiers

PMID22430804
PMCPMC3335951
OpenAlexW2150188652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.